The Venture Codex Logo

The Venture Codex

Overview

Healthcare service provider specializing in dialysis facilities.

Deals ยท 12mo

2

Stage focus

Series A

Geographic focus

United Kingdom

Sector focus

Biotechnology
Health Care
Medical

Investment portfolio

2rounds
NAMEDATESIZE
R1 Therapeutics
Sep 2026Participated
$3 MSeries A
R1 Therapeutics
Mar 2026Participated
$78 MSeries A
R1 Therapeutics
Sep 2026Participated
$3 MSeries A
R1 Therapeutics
Mar 2026Participated
$78 MSeries A
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

U.S. Renal Care: 2 funding rounds are recorded in the selected participation categories.All available history.
U.S. Renal Care: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A02

Monthly Deal Activity

U.S. Renal Care: 2 deals are recorded across 8 months.All available history.
U.S. Renal Care: 2 deals are recorded across 8 months. All available history
MonthDeals
Mar '261
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '261
Oct '260

Sector Breakdown

U.S. Renal Care: Health & Life Sciences is the largest displayed sector by deal count (2 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

U.S. Renal Care: Health & Life Sciences is the largest displayed sector by deal count (2 deals). All available history
SectorDeals
Health & Life Sciences2

Deal Size Distribution

U.S. Renal Care: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

U.S. Renal Care: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

U.S. Renal Care: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

U.S. Renal Care: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
U.S. Renal Care: 7 co-investors are shown, with Abingworth sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

U.S. Renal Care: 7 co-investors are shown, with Abingworth sharing 2 recorded deals. All available history
Co-investorShared deals
Abingworth2
Curie.Bio2
DaVita Venture Group2
F-Prime Capital2
Samsara BioCapital1
SNMA Capital1
SymBiosis1

Investment Strategy

U.S. Renal Care: Led accounts for 0% and participating for 100% of round participation.All available history.
U.S. Renal Care: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating2100%
U.S. Renal Care: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
U.S. Renal Care: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Andy Mitzen

Vice President Of Business Development

Dave Richardson

President, East Division

James (Jim) Hilger

EVP, Chief Financial Officer

Jamie Shelton

Facility Administrator

Mark Caputo

Chairman Of The Board & Chief Executive Officer

Mary Dittrich

Executive Vice President & Chief Medical Officer

Thomas Weinberg

Executive Vice President, General Counsel